OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hellenic Headache Society Recommendations for the Use of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide Pathway for the Prevention of Migraine and Cluster Headache—2023 Update
Dimos D. Mitsikostas, A. Alexoudi, Chrysa Arvaniti, et al.
SN Comprehensive Clinical Medicine (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 9
Dimos D. Mitsikostas, A. Alexoudi, Chrysa Arvaniti, et al.
SN Comprehensive Clinical Medicine (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison
R Mahon, Santosh Tiwari, Mirja Koch, et al.
Journal of Comparative Effectiveness Research (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 5
R Mahon, Santosh Tiwari, Mirja Koch, et al.
Journal of Comparative Effectiveness Research (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 5
The unmet needs in management, the treatment gap and the burden of migraine in Greece: a Delphi consensus and focus group study from patients’ perspective
Michail Vikelis, Georgia Kourlaba, Lia Barba, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Michail Vikelis, Georgia Kourlaba, Lia Barba, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensus
Georgia Kourlaba, Michail Vikelis, Theodoros Karapanayiotides, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Georgia Kourlaba, Michail Vikelis, Theodoros Karapanayiotides, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Cluster Headache Management: Evaluating Diagnostic and Treatment Approaches Among Family and Emergency Medicine Physicians
Buse Rahime Hasırcı Bayır, Ezgi Nazlı, Can Ulutaş
Medicina (2025) Vol. 61, Iss. 3, pp. 437-437
Open Access
Buse Rahime Hasırcı Bayır, Ezgi Nazlı, Can Ulutaş
Medicina (2025) Vol. 61, Iss. 3, pp. 437-437
Open Access
Fremanezumab for the Treatment of Migraine Complicated by Medication Overuse: A Systematic Review
Ibrahim Hajjaj, Carlo Baraldi, Lanfranco Pellesi
Clinical Drug Investigation (2025)
Closed Access
Ibrahim Hajjaj, Carlo Baraldi, Lanfranco Pellesi
Clinical Drug Investigation (2025)
Closed Access
Improvement of comorbid anxiety and depression in patients with migraine treated with injectable preventive calcitonin gene-related peptide antagonists: Review of clinical evidence
Abubker Omaer, Abdulrazaq Albilali, Reem F. Bamogaddam, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 4, pp. 101989-101989
Open Access | Times Cited: 3
Abubker Omaer, Abdulrazaq Albilali, Reem F. Bamogaddam, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 4, pp. 101989-101989
Open Access | Times Cited: 3
Predictors of galcanezumab response in a real-world study of Korean patients with migraine
Seung Ae Kim, Hyemin Jang, Mi Ji Lee
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Seung Ae Kim, Hyemin Jang, Mi Ji Lee
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Placebo responses vary by route of administration in migraine prevention trials. What does this mean?
Christina Deligianni, Paolo Martelletti, Dimos D. Mitsikostas
Journal of Medical Economics (2024) Vol. 27, Iss. 1, pp. 442-444
Open Access | Times Cited: 1
Christina Deligianni, Paolo Martelletti, Dimos D. Mitsikostas
Journal of Medical Economics (2024) Vol. 27, Iss. 1, pp. 442-444
Open Access | Times Cited: 1
Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention
Stephane A. Régnier, Xin Ying Lee
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 1072-1080
Open Access | Times Cited: 1
Stephane A. Régnier, Xin Ying Lee
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 1072-1080
Open Access | Times Cited: 1
